MDMG.L Regulatory News (MDMG)

RESULTS OF THE ANNUAL GENERAL MEETING

10 June 2013 - MD Medical Group Investments Plc ("MD Medical Group", "MDMG" or the "Company" - LSE: MDMG), Russia's leading provider of private women's and children's healthcare, today announces that the Company held its Annual General Meeting of shareholders.

The AGM was held in Limassol, Cyprus on 7 June 2013 at 10 a.m. local time, and had a 100 % quorum with 75,125,010 shares present.

The AGM passed the following resolutions by a majority of members:

1. To adopt the consolidated financial statements of the Company for the financial year ended 31 December 2012, together with the reports of the directors and independent auditors.

2. To re-appoint KPMG Limited as auditors of the Company, to hold office until the conclusion of the next annual general meeting of the Company and to authorize the Board of Directors to determine the remuneration of the auditors.

3. To re-appoint all nine directors of the Company:

Mssrs. Kirill Dmitriev, Mark Kurtser, Elena Mladova and Simon Rowlands, as directors of the Company, for three years, to hold the office until the conclusion of the annual general meeting of shareholders of the Company to be held on 2016, and

Mssrs. Apollon Athanasiades, Elia Nicolaou, Angelos Paphitis, Andreas Petrides and Marios Tofaros, as directors of the Company, for one year, to hold such office until the conclusion of the next annual general meeting of the Company.

4. To approve the distribution by the Company of final dividends, out of the profits made during the year 2012, in the amount of 0.13 USD per ordinary share/GDR.

As indicated by the Company earlier, the dividend record date was set for 7 June 2013. The payment of the dividends is expected by 12 June 2013.

The Minutes of the AGM are available for viewing at the registered office of the Company at 1, Avlonos Maria House, 5th floor 1075 Nicosia, Cyprus and will shortly be available at the National Storage Mechanism of the UK Listing Authority, located at http://www.morningstar.co.uk/uk/.

ENDS

About MD Medical Group

MD Medical Group operates in the highly attractive Russian private healthcare service market and has a leading position in high-quality women's health and paediatrics. The company manages ten modern healthcare facilities, including two hospitals and eight outpatient clinics in Moscow, St. Petersburg, Ufa and Perm. In addition, two franchised outpatient clinics operate in Kyiv and one franchised outpatient clinic in Irkutsk.

The Company's main medical facilities are the Perinatal Medical Center (PMC), a 250-bed medical centre, which opened its doors in 2006, and Lapino hospital, a 182-bed medical centre, which opened at the end of 2012. In 2012, there were 3,253 deliveries in PMC and Lapino. The number of outpatient treatments for 2012 in PMC and the Company's outpatient clinics totalled 446,407. In March 2013, the Company began construction of its third hospital in Ufa.

The Company's shares have been listed on the London Stock Exchange (LSE ticker "MDMG") in the form of Global Depositary Receipts (GDRs) since 12 October 2012.

* * *

Forward-Looking Statements:

This press release contains forward looking statements, which are based on the Company's current expectations and assumptions and may involve known and unknown risks and uncertainties that could cause actual results, performance or events to differ materially from those expressed or implied in such statements. The forward looking statements contained in this press release are based on past trends or activities and should not be taken that such trends or activities will continue in the future. It is believed that the expectations reflected in these statements are reasonable, but they may be affected by a number of variables which could cause actual results or trends to differ materially, including, but not limited to: conditions in the market, market position of the Company, earnings, financial position, cash flows, return on capital and operating margins, anticipated investments and economic conditions; the Company's ability to obtain capital/additional finance; a reduction in demand by customers; an increase in competition; an unexpected decline in revenue or profitability; legislative, fiscal and regulatory developments, including, but not limited to, changes in environmental and health and safety regulations; exchange rate fluctuations; retention of senior management; the maintenance of labour relations; fluctuations in the cost of input costs; and operating and financial restrictions as a result of financing arrangements.

No statement in this press release is intended to constitute a profit forecast, nor should any statements be interpreted to mean that earnings or earnings per share will necessarily be greater or lesser than those for the relevant preceding financial periods for the Company. Each forward looking statement relates only as of the date of the particular statement.